558 posts | Last Activity: 4 minutes 16 seconds ago
Member since: Jul 20, 2015
You also became member just a month or so.
Merrill Lynch was acting in accordance with an underwriting agreement with BA, which, could be acting on behalf of its client.
This also comes into my mind. It should be a great opportunity for shorts to push to pps further, but apparently there has been good buying interest since last Friday.
Can you be more specific as to what accounting items or treatment you are referring to?
It means the SEC has been doing not much about it and somehow allowing naked shorting activities with a blinded eye. Sure, I would do the same if I has an interest in it.
Some of your points are misleading. Believe me, shareholders who sold at the peak and bought back at $4 are extremely happy. Share price of $11 was way overvalued. A drop from the peak can no way be taken as destruction unless one bought at such level and is still holding. The management is doing just well. I have seen good progress in the past year. The company is hiring top notch staff to help develop its pipeline products. I think this is a great move to have a new CMO as well.
Looks to me the debt under the facility provided by SNY would turn into expenses associated with sales. I would not be worried too much about this. As long as MNKD is able to keep its own expenses down and maintain a healthy cash flow, the company will be fine and growing.
Why update someone when he has not yet reported to work?
In the PR it says Chief Medical Officer, Dr. Urbanski will lead MannKind's overall drug development activities and will be a member of the Executive Leadership Team.
Did MNKD mention they would announce & update note exchange on daily basis?
".... if Sanofi isn't willing to properly commercialize it then Mannkind should consider looking for another marketing partner willing to do the job the right way. Mat said wait and let's see."
I do have reservation to believe this is the response to your question from an executive of a public listed corporation. Especially a CFO is supposedly to have a prudent character and being highly sensitive and careful in talking something of this nature. I really would not expect the word "wait" from Mat. I mean what does MNKD want to wait for and for how long in order to take what action?